1. Home
  2. Analysis
  3. Fentanyl-100
  4. Meprobamate

Fentanyl-100 and Meprobamate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fentanyl-100 (fentanyl) and Meprobamate (meprobamate). Common drug interactions include drug toxicity among females and drug toxicity among males.

The phase IV clinical study analyzes what interactions people have when they take Fentanyl-100 and Meprobamate. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Fentanyl-100?

Fentanyl-100 has active ingredients of fentanyl. It is often used in pain. eHealthMe is studying from 7,047 Fentanyl-100 users. Check the latest studies of Fentanyl-100.

What is Meprobamate?

Meprobamate has active ingredients of meprobamate. It is often used in stress and anxiety. eHealthMe is studying from 2,268 Meprobamate users. Check the latest studies of Meprobamate.

On Jul, 13, 2026

11 people who take Fentanyl-100 and Meprobamate together, and have interactions are studied.

Fentanyl-100 and Meprobamate drug interactions.

What are the common drug interactions of Fentanyl-100 and Meprobamate, by gender? *:

female:

  1. Drug toxicity
  2. Completed suicide (act of taking one's own life)
  3. Dizziness
  4. Drug abuse
  5. Drug level increased
  6. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  7. Hypertensive heart disease
  8. Pulmonary oedema (fluid accumulation in the lungs)

male:

  1. Drug toxicity
  2. Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)

What are the common drug interactions of Fentanyl-100 and Meprobamate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Drug toxicity
  2. Completed suicide (act of taking one's own life)

20-29:

  1. Drug toxicity

30-39:

n/a

40-49:

  1. Dizziness
  2. Drug abuse
  3. Drug level increased
  4. Drug toxicity
  5. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  6. Hypertensive heart disease
  7. Pulmonary oedema (fluid accumulation in the lungs)

50-59:

  1. Drug toxicity

60+:

n/a

What are the existing conditions these people have? *

  1. Ill-Defined Disorder: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Fentanyl-100 and Meprobamate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fentanyl-100 and Meprobamate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fentanyl-100:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Meprobamate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fentanyl-100 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meprobamate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl and meprobamate (the active ingredients of Fentanyl-100 and Meprobamate, respectively), and Fentanyl-100 and Meprobamate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.